Wednesday, 20 November 2019

Generics News

  • Canada quarantines APIs by India firm

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2015

    Singapore: Canada has quarantined the health products made with active pharmaceutical ingredients (APIs) from India's Sri Krishna Pharmaceuticals due to data integrity concerns. Health Can...Read more

  • Fosun Pharma listed in CCTV Financial 50 Index Sample Stock

    Generics |  Company results | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2013

    Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Shenzhen Securities Information and CCTV Finance Channel with the index...Read more

  • First generic of diabetes drug Actos approved

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2012

    Singapore: The US FDA has approved world's first generic version of Actos (pioglitazone hydrochloride) tablets. US-based pharma company Mylan Pharmaceuticals, received FDA approval for 15 m...Read more

  • Ranbaxy redesigns strategy to meet regulations

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2012

    The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the first pharmaceutical company of Indian origin to cross a figure of $1.5...Read more

  • Interpol seized $41 mn fake drugs to be sold online

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

    Singapore: Interpol's sixth and the biggest annual worldwide crackdown, Pangea VI has ended in seizing of $41 million worth of illegal pharmaceuticals that were being sold online. The worl...Read more

  • India, China to produce generic of Gilead's TAF

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Aug, 2014

    Singapore: Gilead have allowed generic manufacturers in India and China to produce generic versions of its HBV and HIV drug, tenofovir alafenamide (TAF). The company is in agreement with t...Read more

  • Indian formulation industry to grow by 10-12%

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: The Indian pharmaceutical industry is estimated to continue to experience strong growth in the near-term although there would be some moderation in the growth trajectory, a repor...Read more

  • Dr. Reddy's hires its HR global head from IBM

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: India's pharmaceutical firm Dr. Reddy's has appointed Dr. Sripada Chandrasekhar as the president and global head of human resources. He will also be a member of Dr. Reddy's Manag...Read more

  • Huahai gets China FDA nod to make HIV/AIDS generic

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2013

    Singapore: China-based Zhejiang Huahai Pharma received approval from the China FDA to produce efavirenz. Huahai is the first Chinese drugmaker to receive approval to make the drug. The dru...Read more

  • US firms lobbying to protect patents in India: Report

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

    Singapore: An Indian news report that appeared in Business Line quoted an unidentified DIPP official who claimed that top officials of many US pharmaceutical companies recently met the Depa...Read more

  • Merck aims to expand its China business

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2014

    Singapore: Leading pharma giant Merck has reinforced its commitments towards China, in a bid to strengthen its position among emerging markets. Merck aims to construct its pioneering new ph...Read more

  • Blogger sued by pharma firm for the first time in India

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juridical Sciences, Kolkata, over his alleged defamatory remarks publishe...Read more

  • Actavis sets up APAC headquarter in Singapore

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2014

    Singapore: Global generics firm, Actavis, has opened its regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region. In addit...Read more

  • Indian regulator cracks down on banned drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2013

    Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the country, Drug Controller General of India (DGCI) has directed all companie...Read more

  • Why Mylan sued US FDA over Diovan generic?

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Multinational pharmaceutical company Mylan sued the US Food and Drug Administration (FDA) for approval to sell a generic version of Novartis' blockbuster anti-hypertensive drug Diovan (vals...Read more

  • Ranbaxy now recalls 64,000 bottles of generic heart drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

    Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehensions, recalled more than 64,000 bottles containing tablets of atorvastat...Read more

  • APAC Epilepsy Therapeutics market to touch $1.5 bn by 2019

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2014

    Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, is expected to increase moderately, climbing from USD1.1 billion in 2...Read more

  • Pfizer, Mylan settle litigation over Detrol LA generic

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: Pfizer has settled its litigation against Mylan and Mylan Pharmaceuticals relating to Pfizer's patents covering Detrol LA (tolterodine tartrate) extended-release capsules. The p...Read more